GH Research PLC
GHRS · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Schonharting Florian: Form 4
Insider disclosure · Filed · Report period 08 Sep 2026
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GHRS · G3855L106 - COMMON STOCK
Company details and SEC sources
CIK 0001855129 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GHRS on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Joshua Dawson House, Dawson Street, Dublin 2, Ireland, D02 RY95
- Incorporated in
- Ireland
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields